BACKGROUND: During a microbubble infusion, guided high-mechanical index impulses from a diagnostic two-dimensional transducer improve microvascular recanalization in acute ST-segment elevation myocardial infarction. The purpose of this study was to further elucidate the mechanism of improved microvascular flow in normal and hyperlipidemic atherosclerotic pigs. METHODS: In 14 otherwise normal pigs, acute left anterior descending thrombotic coronary occlusions were created. Pigs subsequently received aspirin, heparin, and half-dose fibrinolytic agent (tenecteplase or tissue plasminogen activator), followed by randomization to either no additional treatment (group I) or a continuous infusion of nontargeted microbubbles and guided high-mechanical index impulses from a three-dimensional transducer (group II). Epicardial recanalization rates, ST-segment resolution, microsphere-derived myocardial blood flow, and ultimate infarct size using myocardial contrast echocardiography were compared. The same coronary thrombosis was created in a set of 12 hypercholesterolemic pigs, which were then treated with the same pharmacologic and ultrasound regimen (group III, n = 6) or the pharmacologic regimen alone (group IV, n = 6). RESULTS: Epicardial recanalization rates in groups I and II were the same (29%), but peri-infarct myocardial blood flow and ultimate infarct size improved after treatment in group II (P < .01 vs group I). In group III, epicardial recanalization was 100% (vs. 50% in group IV), and there were significant reductions in ultimate infarct size (P = .02 compared with group IV). CONCLUSIONS: Guided high-mechanical index impulses from a diagnostic transducer and nontargeted microbubbles improve peri-infarct microvascular flow in acute ST-segment elevation myocardial infarction, even when epicardial recanalization does not occur.
BACKGROUND: During a microbubble infusion, guided high-mechanical index impulses from a diagnostic two-dimensional transducer improve microvascular recanalization in acute ST-segment elevation myocardial infarction. The purpose of this study was to further elucidate the mechanism of improved microvascular flow in normal and hyperlipidemic atheroscleroticpigs. METHODS: In 14 otherwise normal pigs, acute left anterior descending thrombotic coronary occlusions were created. Pigs subsequently received aspirin, heparin, and half-dose fibrinolytic agent (tenecteplase or tissue plasminogen activator), followed by randomization to either no additional treatment (group I) or a continuous infusion of nontargeted microbubbles and guided high-mechanical index impulses from a three-dimensional transducer (group II). Epicardial recanalization rates, ST-segment resolution, microsphere-derived myocardial blood flow, and ultimate infarct size using myocardial contrast echocardiography were compared. The same coronary thrombosis was created in a set of 12 hypercholesterolemicpigs, which were then treated with the same pharmacologic and ultrasound regimen (group III, n = 6) or the pharmacologic regimen alone (group IV, n = 6). RESULTS: Epicardial recanalization rates in groups I and II were the same (29%), but peri-infarct myocardial blood flow and ultimate infarct size improved after treatment in group II (P < .01 vs group I). In group III, epicardial recanalization was 100% (vs. 50% in group IV), and there were significant reductions in ultimate infarct size (P = .02 compared with group IV). CONCLUSIONS: Guided high-mechanical index impulses from a diagnostic transducer and nontargeted microbubbles improve peri-infarct microvascular flow in acute ST-segment elevation myocardial infarction, even when epicardial recanalization does not occur.
Authors: Tadamichi Sakuma; Ibrahim Sari; Craig N Goodman; Jonathan R Lindner; Alexander L Klibanov; Sanjiv Kaul Journal: Cardiovasc Res Date: 2005-06-01 Impact factor: 10.787
Authors: Robert J Siegel; Valentina N Suchkova; Takashi Miyamoto; Huai Luo; Raymond B Baggs; Yoram Neuman; Michael Horzewski; Veijo Suorsa; Sergio Kobal; Todd Thompson; Debra Echt; Charles W Francis Journal: J Am Coll Cardiol Date: 2004-10-06 Impact factor: 24.094
Authors: H Ito; A Maruyama; K Iwakura; S Takiuchi; T Masuyama; M Hori; Y Higashino; K Fujii; T Minamino Journal: Circulation Date: 1996-01-15 Impact factor: 29.690
Authors: Tadamichi Sakuma; Howard Leong-Poi; Nick G Fisher; Norman C Goodman; Sanjiv Kaul Journal: J Am Soc Echocardiogr Date: 2003-01 Impact factor: 5.251
Authors: A Geppert; S Graf; R Beckmann; S Hornykewycz; E Schuster; B R Binder; K Huber Journal: Arterioscler Thromb Vasc Biol Date: 1998-10 Impact factor: 8.311
Authors: J Todd Belcik; Brian H Mott; Aris Xie; Yan Zhao; Sajeevani Kim; Nathan J Lindner; Azzdine Ammi; Joel M Linden; Jonathan R Lindner Journal: Circ Cardiovasc Imaging Date: 2015-04 Impact factor: 7.792
Authors: O'Neil R Mason; Brian P Davidson; Paul Sheeran; Matthew Muller; James M Hodovan; Jonathan Sutton; Jeffry Powers; Jonathan R Lindner Journal: JACC Cardiovasc Imaging Date: 2019-08-14
Authors: Thomas R Porter; Stanley Radio; John Lof; Carr Everbach; Jeffry E Powers; Francois Vignon; William T Shi; Feng Xie Journal: Ultrasound Med Biol Date: 2016-04-12 Impact factor: 2.998
Authors: Gary Z Yu; Filip Istvanic; Xucai Chen; Mehdi Nouraie; Sruti Shiva; Adam C Straub; John J Pacella Journal: Ultrasound Med Biol Date: 2019-12-03 Impact factor: 2.998
Authors: J Todd Belcik; Brian P Davidson; Aris Xie; Melinda D Wu; Mrinal Yadava; Yue Qi; Sherry Liang; Chae Ryung Chon; Azzdine Y Ammi; Joshua Field; Leanne Harmann; William M Chilian; Joel Linden; Jonathan R Lindner Journal: Circulation Date: 2017-02-07 Impact factor: 29.690
Authors: Terry O Matsunaga; Paul S Sheeran; Samantha Luois; Jason E Streeter; Lee B Mullin; Bhaskar Banerjee; Paul A Dayton Journal: Theranostics Date: 2012-12-23 Impact factor: 11.556